Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isracann Biosciences Inc ISCNF

Cannabis
Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural Health Product. The Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The Company's subsidiaries include Isracann Holdings Inc., Praesidio Health Inc., Isracann Biosciences Capital Ltd., Isracann Operations Ltd., Isracann Development Ltd., Isracann Agritech Ltd., Isracann Administrative Services Ltd. and others.


GREY:ISCNF - Post by User

Isracann Biosciences Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(18)
•••
Post by Darshan2on Feb 23, 2022 9:17am
208 Views
Post# 34453230

Isracann to acquire natural health medicine developer

Isracann to acquire natural health medicine developer
  •  

Isracann to acquire natural health medicine developer

  • Isracann Biosciences (OTCPK:ISCNF) to acquire Praesidio Health of Canada.
  • The appointment of Mr. Phil Floucault to the position of company’s CEO in late October of 2021, allowed for a period of investigation, reflection and ultimately offered an opportunity for Mr. Floucault to examine parallel complementary business opportunities within his extensive business network.
  • Company also announces it has signed an agreement with Promethean Marketing to provide digital marketing services.
  • Terms are for the offering of services for one month beginning February 23, 2022.
  • As consideration for the contract, the company has made payments totaling $65,000.







https://seekingalpha.com/news/3804111-isracann-to-acquire-natural-health-medicine-developer?mailingid=26801743&messageid=2900&serial=26801743.57&utm_campaign=rta-stock-news&utm_content=link-1&utm_medium=email&utm_source=seeking_alpha&utm_term=26801743.57
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities